Clinical Trial

Cord Blood Transplantation in Children and Young Adults With Blood Cancer

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of this study is to find out whether Cord Blood Transplantation/CBT as the first or second transplant is an effective treatment for children and young adults with blood cancer.
Protocol Amendment History 2 changes
minor Trial arms changed: 6 -> 2 2026-05-15
notable Trial sites reduced: 7 -> 1 locations 2026-05-15
Trial Details
NCT Number NCT07566377
Lead Sponsor Memorial Sloan Kettering Cancer Center
Conditions Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, Non-hodgkin Lymphoma, Hodgkin Lymphoma, Leukemia, Lymphoma, Graft-versus-host Disease
Enrollment 71 participants
Start Date 2026-04-28
Primary Completion 2030-04-28 (estimated)
Study Completion 2030-04-28 (estimated)
Updated on ClinicalTrials.gov 2026-05-14